Defining a quantitative and reliable relationship between in vitro drug release and in vivo absorption is highly desired for rational development, optimization, and evaluation of controlled-release dosage forms and manufacturing process. During the development of a once-daily extended-release (ER) t
β¦ LIBER β¦
Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation
β Scribed by Nattee Sirisuth; Larry L. Augsburger; Natalie D. Eddington
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 116 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.270
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Once-a-day extended-release dosage form
β
Sandeep Dutta; Yihong Qiu; Emil Samara; Guoliang Cao; G. Richard Granneman
π
Article
π
2005
π
John Wiley and Sons
π
English
β 257 KB
π 1 views
A systematic method for the development
β
Andreas D. Theocharis; John Milias-Argitis; Thomas Zacharias
π
Article
π
2009
π
John Wiley and Sons
π
English
β 660 KB
A systematic development of βsolid-shell
β
R. Hauptmann; K. Schweizerhof
π
Article
π
1998
π
John Wiley and Sons
π
English
β 204 KB
In the present contribution we propose a so-called solid-shell concept which incorporates only displacement degrees of freedom. Thus, some major disadvantages of the usually used degenerated shell concept are overcome. These disadvantages are related to boundary conditions-the handling of soft and h